Cancer is a disease which is getting more and more prevalent in the world now a days and its incidence is increasing due to more industrialization and more sedentary life styles. One of the cancer which commonly affect the female gender is ovarian malignancy which has ranked as the 5th most common malignancy that cause mortality in the female patients and among mortality due to gynecological malignancies, it is on top. Women of every race show risk factors of developing this malignancy. So one of the most important factors in determining the cancer surveillance after establishment of diagnosis of this malignancy is to ascertain the survival rates and life expectancy of ovarian cancer. These rates do differ for different races and also from patient to patient but some common factors influencing survival and life expectancy are patient’s age at diagnosis, family history and time of diagnosis.
As far as the ovarian cancer life expectancy and survival of this malignancy is concerned, it is inversely related with the age of the patient, usually it is not the disease of young age and patients below 40 years of age are not very common. But the survival rates are very high approaching 90% in younger patients. The best survival rates are seen in patients in their 20s and 30s. If the screening of cancer is early then the survival rates are quite high but these decreases with the age and the stage of cancer, the more advance the stage of cancer the less is the life expectancy of the patient.
The survival rates declines further to 85% when women reach the age of 45, at this age the life expectancy is not much and development of breast cancer at the same time has an additional detrimental effect on the survival. If patients reach their 6th decade of life then the ovarian cancer life expectancy declines to 5 to 6 years after complete recovery from the tumor. In cases where patients are physically active at diagnoses then patient can maximally survive fro about 15years but not more than this. As mentioned earlier the survival rates declines rapidly fro patients with advanced stage and at this point chemotherapy and radiotherapy are the best treatment options but most of the time it is just for palliation.
After the age of 65, there is a rapid fall in the life expectancy and the survival which lies between one to two years at most. There are very few evidences which showed ovarian malignancy after 80years, though their quantity is less but they showed comparatively longer survival. But these patients have ill health due to other co-morbid conditions like heart diseases & diabetes. Some long term therapy other than surgery should be advised to these patients as the later can prove fatal due to other health related issues of these patients. As true for other cancers, early screening and delivery of proper treatment can enhance the life expectancy in these patients. So it should be a regular practice for the medical professionals to create public awareness about screening and if diagnosed then proper treatment to improve the outcome of the treatment and in turn enhances the survival rates.